Gelatin-stabilised microemulsion-based organogels facilitates percutaneous penetration of cyclosporin A in vitro and dermal pharmacokinetics in vivo

Journal of Pharmaceutical Sciences

Volumn 96, Issue 11, 2007, Pages 3000-3009

  Liu, Hongzhuo ^a   Wang, Yongjun ^a   Han, Fei ^a   Yao, Huimin ^a   Li, Sanming ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cyclosporin A; in vivo; Microemulsion based organogels; Skin; Topical

Indexed keywords

CYCLOSPORIN A; GELATIN; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; ELECTRIC CONDUCTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYDROGEL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MALE; MICROEMULSION; NEUTRON SCATTERING; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SKIN IRRITATION;

EID: 34547873740     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20898     Document Type: Article

References (23)

1. Lallemand F, Felt-Byeyens O, Besseghir K, Benar-Cohen F, Gumy R. 2003. Cyclosporin A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm 56:307-318.
2. Hultsch T, Kapp A, Spergel J. 2005. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 211:174-187.
3. Vc Ho. 2004. The use of Cyclosporin in psoriasis: a clinical review. Br J Dermatol 150:671-10.
4. Guzzo C. 1997. Recent advances in the treatmet of psoriasis. Dermatol Clin 15:59-68.
5. Zachariae H, Kragballe K, Hansen H. 1997. Renal biopsy findings in long-term Cyclosporin treatment of psoriasis. Br J Dermatol 136:531-535.
6. Duncan JI, Payne SN, Winfield AJ, Ormerod AD, Thomson AW. 1990. Enhanced percutaneous absorption of a novel topical Cyclosporin A formulation and assessment of its immunosuppressive activity. Br J Dermatol 123:631-640.
7. Choi HK, Flynn GL. 1995. Percutaneous absorption and dermal delivery of Cyclosporin A. J Pharm Sci 84:581-583.
8. Boinpally RR, Sen-Lin Zhou, Devraj G, Anne PK, Poondru S, Jasti BR. 2004. Iontophoresis of lecithin vesicles of Cyclosporin A. Int J Pharm 274:185-190.
9. Tran HS, Malli D, Chrzanowski FA, Puc MM, Matthews MS, Hewitt CW. 1999. Site-specific immunosuppression using a new formulation of topical Cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. J Surg Res 83:136-140.
10. Wang S, Kara M, Krishnan TR. 1998. Transdermal delivery of Cyclosporin A using electroporation. J Control Release 50:61-70.
11. Verma DD, Verma S, McElwee KJ, Freyschmidt PP, Hoffman R, Fahr A. 2004. Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. Eur J Dermatol 14:332-338.
12. Liu H, Li S, Wang Y, Yao H, Zhang Y. 2006. Effect of vehicles and enhancers on the topical delivery of Cyclosporin A. Inter J Pharm 311:182-186.
13. Liu H, Li S, Wang Y, Han F, Dong Y. 2006. Bicontinuous water-Aot/Tween85-isopropylmytistate microemulsion: a new vehicle for transdermal delivery of Cyclosporin A. Drug Dev Ind Pharm 32:549-557.
14. Elisseeff J, McIntosh W, Anseth K, Riley S, Ragan P, Langer R. 2000. Photoencapsulation of chondrocytes in poly(ethyleneoxide)-based semi-interpenetrating networks. J Biomed Mater Res 51:164-171.
15. Podual K, Doyle FJ, Peppas NA. 2000. Preparation and dynamic response of cationic copolymer hydrogels containing glucose oxidase. Polymer 41:3975-3983.
16. Haering G, Luisi PL. 1986. Hydrocarbon gels from water-in-oil microemulsions. J Phys Chem 90:5892-5895.
17. Quellet C, Eicke HF, Sager W. 1991. Formation of microemulsion-based gelatin gels. J Phys Chem 95:5642-5655.
18. Atkinson PJ, Robinson BH, Howe AM, Heenan RK. 1991. Structure and stability of microemulsion-based organogels. J Chem Soc Faraday Trans 87:3389-3397.
19. Kantaria S, Rees GD, Lawrence MJ. 1999. Gelatin-stabilized microemulsion-based organogels: rheology and application in iontophoretic transdermal drug delivery. J Control Release 60:355-365.
20. Kantaria S, Rees GD, Lawrence MJ. 2003. Formulation of electrically conducting microemulsion-based organogel. Int J Pharm 250:65-83.
21. Guo J, Ping Q, WU T, HU XF. 2000. Pharmacokinetic of behaviors transdermal delivery and oral administration of Cyclosporin A preparations in mice. J China Pharma Univ 31:340-343.
22. Verma DD, Fahr A. 2004. Synergistic penetration enhancement effect of ethanol and phosphoilipids on the topical delivery of Cyclosporin A. J Control Release 97:55-66.
23. Lopes LB, Collett JH, Bentley MVLB. 2005. Topical delivery of Cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur J Pharm Biopharm 60:25-30.